Literature DB >> 15231703

The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin.

Anthony P Coll1, Benjamin G Challis, Giles S H Yeo, Katherine Snell, Sarah J Piper, David Halsall, Rosemary R Thresher, Stephen O'Rahilly.   

Abstract

The mature adrenal cortex is dependent upon proopiomelanocortin (POMC)-derived peptides for the maintenance of its size, structure, and endocrine function. Recent studies in mice genetically deficient in POMC have suggested that early exposure to POMC-derived peptides might also be necessary for the development of a functionally competent adrenal. We examined adrenal morphology and function in an independent line of mice lacking all POMC-derived peptides (Pomc-/-). Adrenal glands were found in all mice, although the glands of Pomc-/- mice had markedly reduced weight compared with control animals (0.5 +/- 0.1 vs. 2.1 +/- 0.1 mg, respectively; P < 0.05) and had disrupted cortical architecture. In Pomc-/- mice, plasma corticosterone was undetectable, and plasma aldosterone was significantly reduced compared with wild-type mice (498 +/- 88 vs. 1845 +/- 168 nmol/liter, respectively; P < 0.001). Heterozygous mice (Pomc+/-) had smaller adrenal glands with significantly lower levels of corticosterone both basally and in response to CRH and ACTH than wild-type mice, indicating that two functional copies of the Pomc gene are necessary to support the fully normal function of the hypothalamic-pituitary-adrenal axis. Three-month-old Pomc-/- mice were treated for 10 d with a highly specific ACTH analog. This treatment restored adrenal weight, cortical morphology, and plasma corticosterone to the levels seen in wild-type littermates. In conclusion, murine adrenal glands can develop without exposure to endogenous POMC-derived peptides during fetal and neonatal life. Although such glands are atrophic and hypofunctional, exposure to ACTH alone can restore their size, morphology, and corticosterone secretion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15231703     DOI: 10.1210/en.2004-0491

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  24 in total

Review 1.  Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit.

Authors:  Hitoshi Ishimoto; Robert B Jaffe
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

2.  Interrenal organogenesis in the zebrafish model.

Authors:  Yi-Wen Liu
Journal:  Organogenesis       Date:  2007-01       Impact factor: 2.500

Review 3.  The cAMP pathway and the control of adrenocortical development and growth.

Authors:  Cyrille de Joussineau; Isabelle Sahut-Barnola; Isaac Levy; Emmanouil Saloustros; Pierre Val; Constantine A Stratakis; Antoine Martinez
Journal:  Mol Cell Endocrinol       Date:  2011-10-15       Impact factor: 4.102

Review 4.  Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016.

Authors:  Mark D Ericson; Cody J Lensing; Katlyn A Fleming; Katherine N Schlasner; Skye R Doering; Carrie Haskell-Luevano
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-29       Impact factor: 5.187

Review 5.  POMC: The Physiological Power of Hormone Processing.

Authors:  Erika Harno; Thanuja Gali Ramamoorthy; Anthony P Coll; Anne White
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

6.  Effects on hippocampus of lifelong absence of glucocorticoids in the pro-opiomelanocortin null mutant mouse reveal complex relationship between glucocorticoids and hippocampal structure and function.

Authors:  Dirk Ostwald; Jason Karpac; Ute Hochgeschwender
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

7.  Pomc knockout mice have secondary hyperaldosteronism despite an absence of adrenocorticotropin.

Authors:  Kirsten-Berit Linhart; Joseph A Majzoub
Journal:  Endocrinology       Date:  2007-11-08       Impact factor: 4.736

8.  Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis.

Authors:  Dai Chida; Shinichi Nakagawa; So Nagai; Hiroshi Sagara; Harumi Katsumata; Toshihiro Imaki; Harumi Suzuki; Fumiko Mitani; Tadashi Ogishima; Chikara Shimizu; Hayato Kotaki; Shigeru Kakuta; Katsuko Sudo; Takao Koike; Mitsumasa Kubo; Yoichiro Iwakura
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-07       Impact factor: 11.205

9.  Glucocorticoid receptor haploinsufficiency causes hypertension and attenuates hypothalamic-pituitary-adrenal axis and blood pressure adaptions to high-fat diet.

Authors:  Z Michailidou; R N Carter; E Marshall; H G Sutherland; D G Brownstein; E Owen; K Cockett; V Kelly; L Ramage; E A S Al-Dujaili; M Ross; I Maraki; K Newton; M C Holmes; J R Seckl; N M Morton; C J Kenyon; K E Chapman
Journal:  FASEB J       Date:  2008-08-12       Impact factor: 5.191

Review 10.  In search of adrenocortical stem and progenitor cells.

Authors:  Alex C Kim; Ferdous M Barlaskar; Joanne H Heaton; Tobias Else; Victoria R Kelly; Kenneth T Krill; Joshua O Scheys; Derek P Simon; Alessia Trovato; Wei-Hsiung Yang; Gary D Hammer
Journal:  Endocr Rev       Date:  2009-04-29       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.